KDKusuma Sai Davuluri

Kusuma Sai Davuluri

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Kusuma Sai Davuluri has a total of 16 co-authors. Here are the top co-authors by number of shared publications:

  • Devendra Singh Chauhan

    Department of Microbiology and Molecular Biology, ICMR-National JALMA Institute for Leprosy and Other Mycobacterial Diseases, Tajganj, Agra, India

    4 shared publications
  • Ajay Vir Singh

    Department of Microbiology and Molecular Biology, National JALMA Institute for Leprosy and Other Mycobacterial Diseases, Tajganj, India

    3 shared publications
  • Amit Kumar Singh

    Department of Animal Experimentation Facility, National JALMA Institute for Leprosy and Other Mycobacterial Diseases, Tajganj, India

    3 shared publications
  • Shoor Vir Singh

    Department Biotechnology, GLA University, Mathura, India

    3 shared publications
  • Shweta Kushwaha

    Department of Microbiology and Molecular Biology, ICMR, National JALMA Institute for Leprosy and Other Mycobacterial Diseases, Tajganj, Agra, India

    2 shared publications
  • Ajay Vir Singh

    Department of Microbiology and Molecular Biology, ICMR-National JALMA Institute for Leprosy and Other Mycobacterial Diseases, Agra, India

    1 shared publication

Latest Publications

  • Open Access

    Dominant negative biologics normalise the tumour necrosis factor (TNF-α) induced angiogenesis which exploits the Mycobacterium tuberculosis dissemination

    by Kusuma Sai Davuluri, Amit Kumar Singh, Vimal Kumar Yadav, Ajay Vir Singh, Shoor Vir Singh, Devendra Singh Chauhan

    Tumor necrosis factor (TNF) is known to promote T cell migration and increase the expression of vascular endothelial growth factor (VEGF) and chemokines. The administration of Xpro-1595, a dominant-negative TNF (DN-TNF) engineered to selectively inactivate soluble TNF (solTNF), has been extensively studied and proven effective in reducing TNF production without suppressing innate immunity during infection. The literature also supports the involvement of glutamic acid-leucine-arginine (ELR+) chemokines and VEGF in angiogenesis and the spread of infections. In this study, we administered Xpro-1595 to guinea pigs to selectively inhibit solTNF, aiming to assess its impact on Mycobacterium tuberculosis (M.tb) dissemination, bacterial growth attenuation, and immunological responses. We conducted immunohistochemical analyses, immunological assays, and colony enumeration to comprehensively study the effects of Xpro-1595 by comparing with anti-TB drugs treated M.tb infected guinea pigs. Throughout the infection and treatment period, we measured the levels of Interleukin-12 subunit alpha (IL-12), Interferon-gamma (IFN-γ), TNF, Tumor growth factor (TGF), and T lymphocytes using ELISA. Our findings revealed a reduction in M.tb dissemination and inflammation without compromising the immune response during Xpro-1595 treatment. Notably, Xpro-1595 therapy effectively regulated the expression of VEGFA and ELR + chemokines, which emerged as key factors contributing to infection dissemination. Furthermore, this treatment influenced the migration of CD4 T cells in the early stages of infection, subsequently leading to a reduced T cell response and controlled proinflammatory signalling, thus mitigating inflammation. Our study underscores the pivotal role of solTNF in the dissemination of M.tb to other organs. This preliminary investigation sheds light on the involvement of solTNF in the mechanisms underlying M.tb dissemination, although further in-depth research is warranted to fully elucidate its role in this process.


  • Open Access

    Atorvastatin Potentially Reduces Mycobacterial Severity through Its Action on Lipoarabinomannan and Drug Permeability in Granulomas

    by Kusuma Sai Davuluri, Amit Kumar Singh, Ajay Vir Singh, Pooja Chaudhary, Sunil Kumar Raman, Shweta Kushwaha, Shoor Vir Singh, Devendra Singh Chauhan

    Mycobacterium tuberculosis binds to and enters the macrophage via the cell membrane cholesterol. M. tuberculosis limits phagosomal maturation and activation without engaging in phagocytosis. Aggregation of cholesterol in the cell wall of M. tuberculosis and an increase in the vascularity at the granuloma site reduce the permeability of rifampicin and isoniazid concentrations.


  • Open Access

    Anti‑CXCR4 chemokine receptor, motixafortide, as an adjunct treatment with anti‑TB drugs decreases the bacterial burden by improving drug distribution

    by Kusuma Sai Davuluri, Amit Kumar Singh, Ajay Vir Singh, Vimal Kumar, Shoor Vir Singh, Devendra Singh Chauhan

    C‑X‑C motif chemokine receptor 4 (CXCR4) is involved in the migration of bloodcells and the formation of blood vessels. It is expressed on blood cells and other immune cells such as dendritic cells and lymphocytes. Mycobacterium tuberculosis (M.tb) induces granuloma‑associated angiogenesis, which is associated with the mycobacterial‑induced expression of CXCR4. However, the significance of pathogen‑induced angiogenesis remains elusive. The aim of the present study was to investigate the role and expression levels of CXCR4 during M.tb infection. To inhibit CXCR4, motixafortide, an antagonist for CXCR4, was used. The effect of motixafortide on M.tb dissemination, attenuation of bacterial growth and immunological responses in a guinea pig animal model was extensively studied using immunohistochemistry, as well as immunological and colony enumeration assays. The pharmacokinetics of first‑line drugs in plasma, the lungs, and granuloma were evaluated following the inhibition of the expression of CXCR4 through motixafortide therapy. The results revealed that CXCR4 stimulation induced the expression of vascular endothelial growth factor‑A (VEGFA) in M.tb‑infected guinea pigs. Improvement in the pharmacokinetic parameters and early bacterial clearance in the spleen were observed in motixafortide anti‑tuberculosis (TB) drug therapy in contrast to therapy with first‑line drugs alone. G ranulomatous capture of first line drugs combined with motixafortide may have significant implications through different mechanisms. In the present study, it was demonstrated that CXCR4 inhibitors may be used as a therapeutic strategy to combat granuloma‑angiogenesis by interfering with VEGFA signalling and controlling the spread of M.tb infection.

  • Open Access

    microRNAs associated with the pathogenesis and their role in regulating various signaling pathways during Mycobacterium tuberculosis infection

    by Kusuma Sai Davuluri, Devendra S. Chauhan

    Despite more than a decade of active study, tuberculosis (TB) remains a serious health concern across the world, and it is still the biggest cause of mortality in the human population. Pathogenic bacteria recognize host-induced responses and adapt to those hostile circumstances. This high level of adaptability necessitates a strong regulation of bacterial metabolic characteristics. Furthermore, the immune reponse of the host virulence factors such as host invasion, colonization, and survival must be properly coordinated by the pathogen. This can only be accomplished by close synchronization of gene expression. Understanding the molecular characteristics of mycobacterial pathogenesis in order to discover therapies that prevent or resolve illness relies on the bacterial capacity to adjust its metabolism and replication in response to various environmental cues as necessary. An extensive literature details the transcriptional alterations of host in response to in vitro environmental stressors, macrophage infection, and human illness. Various studies have recently revealed the finding of several microRNAs (miRNAs) that are believed to play an important role in the regulatory networks responsible for adaptability and virulence in Mycobacterium tuberculosis. We highlighted the growing data on the existence and quantity of several forms of miRNAs in the pathogenesis of M. tuberculosis, considered their possible relevance to disease etiology, and discussed how the miRNA-based signaling pathways regulate bacterial virulence factors.


  • Stimulated expression of ELR+ chemokines, VEGFA and TNF-AIP3 promote mycobacterial dissemination in extrapulmonary tuberculosis patients and Cavia porcellus model of tuberculosis

    by Kusuma Sai Davuluri, Amit Kumar Singh, Vimal Kumar, Shoor Vir Singh, Ajay Vir Singh, Santhosh Kumar, Rajbala Yadav, Shweta Kushwaha, Devendra Singh Chauhan